Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in South Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in South Carolina
| Provider | Medicare | Services |
|---|---|---|
| Mayes, Michael M.D. | $44.37 | 11 |
South Carolina Pricing in Context
In South Carolina, CPT code 86328 (Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative) carries an average Medicare payment of $42.26 — 5% below the national benchmark of $44.34. 12 providers across the state submitted claims for this procedure in 2023, performing 82 total services. Individual payments in SC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in South Carolina is $93.88, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in South Carolina lands near $99.32, with self-pay cash prices typically around $57.51. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost in South Carolina?
The average Medicare payment for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in South Carolina is $42.26, which is 5% below the national average of $44.34. Providers in SC typically bill $93.88 for this procedure.
What does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost with insurance in South Carolina?
With commercial insurance in South Carolina, Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs an estimated $99.32. Without insurance, the estimated cash price is $57.51. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in South Carolina?
12 providers in South Carolina billed Medicare for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in 2023, performing 82 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cheaper in South Carolina than the national average?
Yes — Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs 5% below the national average in South Carolina. The state average Medicare payment is $42.26 compared to $44.34 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.